8β-hydroxy-3-oxopimar-15-ene exerts anti-inflammatory effects by inhibiting ROS-mediated activation of the TRAF6-ASK1-p38 signaling pathway

References

• Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002;20:825–852
   PubMed Web of Science ®Google Scholar
• Larsen GL, Henson PM. Mediators of inflammation. Annu Rev Immunol 1983;1:335–359
   PubMed Web of Science ®Google Scholar
• Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002;2:787–795
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001;1:135–145
   PubMed Web of Science ®Google Scholar
• Schnare M, Barton GM, Holt AC, et al. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001;2:947–950
   PubMed Web of Science ®Google Scholar
• Hoffmann JA, Reichhart JM. Drosophila innate immunity: an evolutionary perspective. Nat Immunol 2002;3:121–126
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–899
   PubMed Web of Science ®Google Scholar
• Takatsuna H, Kato H, Gohda J, et al. Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling. J Biol Chem 2003;278:12144–12150
   PubMed Web of Science ®Google Scholar
• Matsuzawa A, Saegusa K, Noguchi T, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 2005;6:587–592
   PubMed Web of Science ®Google Scholar
• Nishitoh H, Matsuzawa A, Tobiume K, et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 2002;16:1345–1355
   PubMed Web of Science ®Google Scholar
• Ichijo H, Nishida E, Irie K, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997;275:90–94
   PubMed Web of Science ®Google Scholar
• Ahn KS, Aggarwal BB. Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci 2005;1056:218–233
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066–1071
   PubMed Web of Science ®Google Scholar
• Craig R, Larkin A, Mingo AM, et al. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J Biol Chem 2000;275:23814–23824
   PubMed Web of Science ®Google Scholar
• Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax 1998;53:601–612
   PubMed Web of Science ®Google Scholar
• Yang HO, Suh DY, Han BH. Isolation and characterization of platelet-activating factor receptor binding antagonists from Biota orientalis. Planta Med 1995;61:37–40
   PubMed Web of Science ®Google Scholar
• Lee EJ, Kim C, Kim JY, et al. Inhibition of LPS-induced inflammatory biomarkers by ethyl acetate fraction of Patrinia scabiosaefolia through suppression of NF-kappaB activation in RAW 264.7 cells. Immunopharmacol Immunotoxicol 2012;34:282–291
   PubMed Web of Science ®Google Scholar
• Lee G, Choi TW, Kim C, et al. Anti-inflammatory activities of Reynoutria elliptica through suppression of mitogen-activated protein kinases and nuclear factor-kappaB activation pathways. Immunopharmacol Immunotoxicol 2012;34:454–464
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim HJ, Kim SM, et al. Methylene chloride fraction of the leaves of Thuja orientalis inhibits in vitro inflammatory biomarkers by blocking NF-kappaB and p38 MAPK signaling and protects mice from lethal endotoxemia. J Ethnopharmacol 2011;133:687–695
   PubMed Web of Science ®Google Scholar
• Lee HJ, Choi TW, Kim HJ, et al. Anti-Inflammatory activity of Angelica keiskei through suppression of mitogen-activated protein kinases and nuclear factor-kappaB activation pathways. J Med Food 2010;13:691–699
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996;87:13–20
   PubMed Web of Science ®Google Scholar
• Da Silva J, Pierrat B, Mary JL, Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 1997;272:28373–28380
   PubMed Web of Science ®Google Scholar
• Chen CC, Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol 1999;55:481–488
   PubMed Web of Science ®Google Scholar
• Hsu HY, Wen MH. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002;277:22131–22139
   PubMed Web of Science ®Google Scholar
• Posadas I, Terencio MC, Guillen I, et al. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Naunyn Schmiedebergs Arch Pharmacol 2000;361:98–106
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Prasad S, Reuter S, et al. Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach. Curr Drug Targets 2011;12:1595–1653
   PubMed Web of Science ®Google Scholar
• Marcus JS, Karackattu SL, Fleegal MA, Sumners C. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia 2003;41:152–160
   PubMed Web of Science ®Google Scholar
• Schrader LI, Kinzenbaw DA, Johnson AW, et al. IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol 2007;27:2576–2581
   PubMed Web of Science ®Google Scholar
• Mannel DN, Echtenacher B. TNF in the inflammatory response. Chem Immunol 2000;74:141–161
   PubMedGoogle Scholar
• Glauser MP. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 1996;52:9–17
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 2002;12:9–18
   PubMed Web of Science ®Google Scholar
• Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 2003;52:144–151
   PubMed Web of Science ®Google Scholar
• Kristof AS, Marks-Konczalik J, Moss J. Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J Biol Chem 2001;276:8445–8452
   PubMed Web of Science ®Google Scholar
• Guan Z, Buckman SY, Pentland AP, et al. Induction of cyclooxygenase-2 by the activated MEKK1 → SEK1/MKK4 → p38 mitogen-activated protein kinase pathway. J Biol Chem 1998;273:12901–12908
   PubMed Web of Science ®Google Scholar
• Kirkwood KL, Rossa JrC. The potential of p38 MAPK inhibitors to modulate periodontal infections. Curr Drug Metab 2009;10:55–67
   PubMed Web of Science ®Google Scholar
• Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000;279:L1005–1028
   PubMed Web of Science ®Google Scholar
• Kamata H, Hirata H. Redox regulation of cellular signalling. Cell Signal 1999;11:1–14
   PubMed Web of Science ®Google Scholar